News

Some femtech companies struggle to get their ads approved on social media platforms due to prohibited-content rules and confusion of the rules. 

Panelists at DTx East discuss the journey to implementing digital therapeutics into pharma and say more partnerships are likely.

The startup will use the funding to help expand its platform of patient communication and digital care solutions.

Funding will enable the company to expand its app for chronic joint pain to the US and further across Europe.

Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders.

Panelists at DTx East discuss the difference between 510(k) clearances and enforcement discretions, and why research should go beyond the FDA threshold. 

Initially, Amwell planned to sell 35 million shares between $14 and $16 with up to 5.2 million additional shares for underwriters. 

A new analysis of published RCTs did see significant benefits among short-term and single-focus app interventions, but noted that "relatively few high-quality studies have been conducted" in this area.

The LumiHealth app is available in the App Store for pre-order now, and the two-year program will be offered from late October 2020.

Activist short seller Citron Research called the Israeli digital X-ray company out on its limited R&D expenditure, suspicious distribution agreements and other factors. Nanox has described the report as incorrect and misleading.